Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.51% to 1,713.40 Indian rupees Monday, on what proved to be an ...

Sun Pharmaceutical Industries Ltd. closed 13.20% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

Sun Pharma announced a 15 per cent year-on-year (YoY) increase, reaching ₹2,903 crore for the quarter ending December 2024. The company also recorded an exceptional item of ₹316 crore during ...

BENGALURU (Reuters) -India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.

12 May, 2015 16 Mar, 2016 5:116 244 For every 116 shares held; holder is entitled to apply 5 rights shares at a premium of RS 244 14 Jul, 2011 23 Aug, 2012 1:7 66 For every 7 shares held; holder ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

On the previous day, Sun Pharma's stock closed at Rs 1,749.80, with no change in percentage, and a trading volume of 1,371,545 shares.

Considering today's low, the Nifty pharma index has fallen over 7 per cent in the last three days. On a monthly scale, the index has declined nearly 12 per cent against a 3 per cent fall in the ...

AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements. Stocks including ONGC, Sun Pharma, IndusInd Bank, Nestle, Tata Power, Waaree Energies, IRB Infra ...